Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day : a systematic review and economic evaluation
Date
2011
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Hislop, J, Quayyum, Z, Elders, A, Fraser, C, Jenkinson, D, Mowatt, G, Sharma, P, Vale, L & Petty, R 2011, 'Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day : a systematic review and economic evaluation', Health Technology Assessment, vol. 15, no. 25, pp. 1-178. https://doi.org/10.3310/hta15250